MPM BioVentures 2014, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 34,198 shares at $27.53 ($939K) on 2021-10-15, disclosed to the SEC on 2021-10-18.
Open-market sale of $939k ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.53 | 8,893 | $245K | 26.1% |
| 2 | $27.53 | 8,893 | $245K | 26.1% |
| 3 | $28.01 | 2,039 | $57K | 6.1% |
| 4 | $28.01 | 2,039 | $57K | 6.1% |
| 5 | $27.14 | 6,167 | $167K | 17.8% |
| 6 | $27.14 | 6,167 |
| $167K |
| 17.8% |
| Total | $27.45 avg | 34,198 | $939K | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |